Island Pharmaceuticals Secures R&D Tax Refund Boost
Island Pharmaceuticals Ltd (AU:ILA) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Island Pharmaceuticals has received an $865,230 refund under Australia’s R&D Tax Incentive, which has allowed them to repay a loan from Radium Capital. This funding comes as the company advances its clinical programs, including the promising ISLA-101 nearing a Phase 2a data readout, and explores new assets like galidesivir.
For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.
Trending Articles
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.